# Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management

> **NCT06420245** · NA · RECRUITING · sponsor: **Legacy Medical Consultants** · enrollment: 240 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** Orion TM Amniotic Membrane Allograft
- **PROCEDURE:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT06420245
- **Lead sponsor:** Legacy Medical Consultants
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2026-11
- **Final completion:** 2027-07
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06420245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06420245, "Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06420245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*